Spetea M - Search Results

1

Opioid receptors and their ligands in the musculoskeletal system and relevance for pain control.

Spetea M. Spetea M. Curr Pharm Des. 2013;19(42):7382-90. doi: 10.2174/13816128113199990363. Curr Pharm Des. 2013. PMID: 23448480 Review.

2

Alteration in endogenous opioid systems due to chronic inflammatory pain conditions.

Spetea M, Rydelius G, Nylander I, Ahmed M, Bileviciute-Ljungar I, Lundeberg T, Svensson S, Kreicbergs A. Spetea M, et al. Eur J Pharmacol. 2002 Jan 25;435(2-3):245-52. doi: 10.1016/s0014-2999(01)01554-0. Eur J Pharmacol. 2002. PMID: 11821033

3

In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function.

Spetea M, Bohotin CR, Asim MF, Stübegger K, Schmidhammer H. Spetea M, et al. Eur J Pharm Sci. 2010 Sep 11;41(1):125-35. doi: 10.1016/j.ejps.2010.05.018. Epub 2010 Jun 18. Eur J Pharm Sci. 2010. PMID: 20600882 Free PMC article.

4

Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.

Spetea M, Windisch P, Guo Y, Bileviciute-Ljungar I, Schütz J, Asim MF, Berzetei-Gurske IP, Riba P, Kiraly K, Fürst S, Al-Khrasani M, Schmidhammer H. Spetea M, et al. J Med Chem. 2011 Feb 24;54(4):980-8. doi: 10.1021/jm101211p. Epub 2011 Jan 14. J Med Chem. 2011. PMID: 21235243 Free PMC article.

5

Recent advances in the development of 14-alkoxy substituted morphinans as potent and safer opioid analgesics.

Spetea M, Schmidhammer H. Spetea M, et al. Curr Med Chem. 2012;19(15):2442-57. doi: 10.2174/092986712800269308. Curr Med Chem. 2012. PMID: 22455592 Review.

6

Synthesis and characterization of thiazolo- and thiazinomorphinans and their intermediate products as novel opioid-active derivatives.

Sipos A, Follia V, Berényi S, Antus S, Schmidhammer H, Spetea M. Sipos A, et al. Among authors: spetea m. Arch Pharm (Weinheim). 2012 Nov;345(11):852-8. doi: 10.1002/ardp.201200176. Epub 2012 Aug 10. Arch Pharm (Weinheim). 2012. PMID: 22886624

7

Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening.

Spetea M, Asim MF, Noha S, Wolber G, Schmidhammer H. Spetea M, et al. Curr Pharm Des. 2013;19(42):7362-72. doi: 10.2174/138161281942140105162601. Curr Pharm Des. 2013. PMID: 23448472

8

Functionalization of the carbonyl group in position 6 of morphinan-6-ones. Development of novel 6-amino and 6-guanidino substituted 14-alkoxymorphinans.

Schmidhammer H, Spetea M, Windisch P, Schütz J, Riba P, Al-Khrasani M, Furst S. Schmidhammer H, et al. Among authors: spetea m. Curr Pharm Des. 2013;19(42):7391-9. doi: 10.2174/138161281942140105164804. Curr Pharm Des. 2013. PMID: 23448473 Review.

9

The µ opioid receptor and ligands acting at the µ opioid receptor, as therapeutics and potential therapeutics.

Spetea M, Asim MF, Wolber G, Schmidhammer H. Spetea M, et al. Curr Pharm Des. 2013;19(42):7415-34. doi: 10.2174/13816128113199990362. Curr Pharm Des. 2013. PMID: 23448479 Review.

10

Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.

Ben Haddou T, Malfacini D, Calo G, Aceto MD, Harris LS, Traynor JR, Coop A, Schmidhammer H, Spetea M. Ben Haddou T, et al. Among authors: spetea m. Mol Pain. 2014 Jul 24;10:48. doi: 10.1186/1744-8069-10-48. Mol Pain. 2014. PMID: 25059282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters